Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Mast cell activation syndromes (MCASs) are defined by systemic severe and recurrent mast cell activation, usually in form of anaphylaxis, a substantial, event-related increase of the serum tryptase level beyond the individual’s baseline and a response of the symptomatology to drugs directed against mast cells, mast cell-derived mediators, or mediator effects. A number of predisposing genetic conditions, underlying allergic and other hypersensitivity states, and related comorbidities can contribute to the clinical manifestation of MCASs. These conditions include hereditary alpha tryptasemia, mastocytosis with an expansion of clonal KIT-mutated mast cells, atopic diathesis, and overt IgE-dependent and IgE-independent allergies. Several of these conditions have overlapping definitions and diagnostic criteria and may also develop concomitantly in the same patient. However, although criteria and clinical features overlap, each of these conditions is characterized by a unique constellation of variables and diagnostic criteria. Since two, three, or more conditions can coexist in the same patient, with obvious clinical implications, it is of crucial importance to diagnose the variant of MCAS precisely and to take all accompanying, underlying and potentially complicating conditions, and comorbidities into account when establishing the management plan. Indeed, most of these patients require multidisciplinary investigations and only a personalized treatment approach can lead to an optimal management plan providing an optimal quality of life and low risk of anaphylaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MCAS is defined by severe recurrent systemic symptoms related to MCA, which resemble anaphylaxis.8,9,13”
From Mast cell activation syndrome: Current understanding and research needs (2024) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These criteria were developed by consensus based on literature review and expert opinion, have been validated, and are considered standard.6–9”
From Mast cell activation syndrome: Current understanding and research needs (2024) · cites this paper as [9]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A tryptase > 20 ng/mL serves as a minor criterion to diagnose systemic mastocytosis and an increase in tryptase > 20% + 2 during an acute event is a required criterion in the diagnosis of mast cell activation syndrome.”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [13]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, MCAS has been reported in patients with hereditary a-tryptasemia (HaT), an autosomal dominant genetic trait caused by an increased copy-number of the atryptase gene TPSAB1, resulting in increased baseline serum tryptase levels.7,8”
From Low Prevalence of Idiopathic Mast Cell Activation Syndrome Among 703 Patients With Suspected Mast Cell Disorders (2024) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationNagata, H., Worobec, A. S., Oh, C. K., Chowdhury, B. A., Tannenbaum, S., Suzuki, Y., & Metcalfe, D. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10560 · Cited by 872
Furitsu, T., Tsujimura, T., Tono, T., Ikeda, H., Kitayama, H., Koshimizu, U., Sugahara, H., Butterfield, J. H., Ashman, L. K., & Kanayama, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116761 · Cited by 816
Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
Valent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationBrockow, K., Jofer, C., Behrendt, H., & Ring, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01569.x · Cited by 523
Self-citationMast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Self-citationEfficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis
Gotlib, J., Kluin-Nelemans, H. C., George, T. I., Akin, C., Sotlar, K., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Sternberg, D. W., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513098 · Cited by 488
Self-citationDiagnostic Value of Tryptase in Anaphylaxis and Mastocytosis
Schwartz, L. B. (2006) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2006.05.010 · Cited by 477
Galli, S. J., & Tsai, M. (2010) · European Journal of Immunology · doi:10.1002/eji.201040559 · Cited by 403
Lyons, J. J., Yu, X., Hughes, J. D., Le, Q. T., Jamil, A., Bai, Y., Ho, N., Zhao, M., Liu, Y., O'Connell, M. P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3696 · Cited by 394
Bonadonna, P., Perbellini, O., Passalacqua, G., Caruso, B., Colarossi, S., Dal Fior, D., Castellani, L., Bonetto, C., Frattini, F., Dama, A., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.018 · Cited by 392
Self-citationMast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns
Galli, S. J., Gaudenzio, N., & Tsai, M. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-071719-094903 · Cited by 367
Mast cell activation syndrome: Proposed diagnostic criteria
Akin, C., Valent, P., & Metcalfe, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.035 · Cited by 327
Self-citationArock, M., Sotlar, K., Akin, C., Broesby-Olsen, S., Hoermann, G., Escribano, L., Kristensen, T. K., Kluin-Nelemans, H. C., Hermine, O., Dubreuil, P., et al. (2015) · Leukemia · doi:10.1038/leu.2015.24 · Cited by 290
Self-citationMechanisms of mast cell signaling in anaphylaxis
Metcalfe, D. D., Peavy, R. D., & Gilfillan, A. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.035 · Cited by 283
Diagnostic criteria for atopic dermatitis: a systematic review
Brenninkmeijer, E. E. A., Schram, M. E., Leeflang, M. M. G., Bos, J. D., & Spuls, P. I. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08412.x · Cited by 256
Cladribine therapy for systemic mastocytosis
Kluin-Nelemans, H. C. (2003) · Blood · doi:10.1182/blood-2003-05-1699 · Cited by 248
Valent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2234 · Cited by 247
Self-citationAkin, C., Scott, L. M., Kocabas, C. N., Kushnir-Sukhov, N., Brittain, E., Noel, P., & Metcalfe, D. D. (2007) · Blood · doi:10.1182/blood-2006-06-028100 · Cited by 240
Lyons, J. J., Chovanec, J., O’Connell, M. P., Liu, Y., Šelb, J., Zanotti, R., Bai, Y., Kim, J., Le, Q. T., DiMaggio, T., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.035 · Cited by 230
Self-citationProposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome
Valent, P., Akin, C., Bonadonna, P., Hartmann, K., Brockow, K., Niedoszytko, M., Nedoszytko, B., Siebenhaar, F., Sperr, W. R., Oude Elberink, J. N. G., et al. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.01.006 · Cited by 225
Self-citationInterleukin-4 receptor signaling pathways in asthma pathogenesis
Chatila, T. A. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.08.004 · Cited by 211
Signal Transduction by the High-Affinity Immunoglobulin E Receptor FcεRI: Coupling Form to Function
Nadler, M. J. S., Matthews, S. A., Turner, H., & Kinet, J.-P. (2001) · Advances in Immunology · doi:10.1016/s0065-2776(01)76022-1 · Cited by 203
Greiner, G., Sprinzl, B., Górska, A., Ratzinger, F., Gurbisz, M., Witzeneder, N., Schmetterer, K. G., Gisslinger, B., Uyanik, G., Hadzijusufovic, E., et al. (2021) · Blood · doi:10.1182/blood.2020006157 · Cited by 189
Self-citationValent, P., Akin, C., Hartmann, K., Nilsson, G., Reiter, A., Hermine, O., Sotlar, K., Sperr, W. R., Escribano, L., George, T. I., et al. (2020) · Theranostics · doi:10.7150/thno.46719 · Cited by 180
Self-citationSyk deficiency in nonreleaser basophils☆☆☆★
Kepley, C. L., Youssef, L., Andrews, R. P., Wilson, B. S., & Oliver, J. M. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70367-2 · Cited by 173
O’Sullivan, S., Dahlén, B., Dahlén, S.-E., & Kumlin, M. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70167-7 · Cited by 163
The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis
Owen, J. L., Vakharia, P. P., & Silverberg, J. I. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0340-7 · Cited by 163
Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy
Niedoszytko, M., De Monchy, J., Van Doormaal, J. J., Jassem, E., & Oude Elberink, J. N. G. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02118.x · Cited by 157
Self-citationLong-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis
Barete, S., Lortholary, O., Damaj, G., Hirsch, I., Chandesris, M. O., Elie, C., Hamidou, M., Durieu, I., Suarez, F., Grosbois, B., et al. (2015) · Blood · doi:10.1182/blood-2014-12-614743 · Cited by 153
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
DeAngelo, D. J., Radia, D. H., George, T. I., Robinson, W. A., Quiery, A. T., Drummond, M. W., Bose, P., Hexner, E. O., Winton, E. F., Horny, H.-P., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01538-9 · Cited by 153
Gotlib, J., Reiter, A., Radia, D. H., Deininger, M. W., George, T. I., Panse, J., Vannucchi, A. M., Platzbecker, U., Alvarez-Twose, I., Mital, A., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01539-8 · Cited by 151
Fritsche‐Polanz, R., Jordan, J., Feix, A., Sperr, W. R., Sunder‐Plassmann, G., Valent, P., & Födinger, M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02783.x · Cited by 143
Self-citationLyons, J. J., Sun, G., Stone, K. D., Nelson, C., Wisch, L., O'Brien, M., Jones, N., Lindsley, A., Komarow, H. D., Bai, Y., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.039 · Cited by 136
Sonneck, K., Florian, S., Müllauer, L., Wimazal, F., Födinger, M., Sperr, W. R., & Valent, P. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000096442 · Cited by 129
Self-citationLe, Q. T., Lyons, J. J., Naranjo, A. N., Olivera, A., Lazarus, R. A., Metcalfe, D. D., Milner, J. D., & Schwartz, L. B. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190701 · Cited by 126
Zanotti, R., Lombardo, C., Passalacqua, G., Caimmi, C., Bonifacio, M., De Matteis, G., Perbellini, O., Rossini, M., Schena, D., Busa, M., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.035 · Cited by 123
Self-citationWeiler, C. R., Austen, K. F., Akin, C., Barkoff, M. S., Bernstein, J. A., Bonadonna, P., Butterfield, J. H., Carter, M., Fox, C. C., Maitland, A., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.023 · Cited by 123
Self-citationMast cell activation syndromes: definition and classification
Valent, P. (2013) · Allergy · doi:10.1111/all.12126 · Cited by 120
Self-citationBroesby‐Olsen, S., Vestergaard, H., Mortz, C. G., Jensen, B., Havelund, T., Hermann, A. P., Siebenhaar, F., Møller, M. B., Kristensen, T. K., Bindslev‐Jensen, C., et al. (2018) · Allergy · doi:10.1111/all.13237 · Cited by 112
Baretto, R. L., Beck, S., Heslegrave, J., Melchior, C., Mohamed, O., Ekbote, A., Huissoon, A. P., & Krishna, M. T. (2017) · Allergy · doi:10.1111/all.13226 · Cited by 111
Saleh, R., Wedeh, G., Herrmann, H., Bibi, S., Cerny-Reiterer, S., Sadovnik, I., Blatt, K., Hadzijusufovic, E., Jeanningros, S., Blanc, C., et al. (2014) · Blood · doi:10.1182/blood-2013-10-534685 · Cited by 109
Self-citationBonadonna, P., González‐de‐Olano, D., Zanotti, R., Riccio, A., Ferrari, L. D., Lombardo, C., Rogkakou, A., Escribano, L., Álvarez‐Twöse, I., Matito, A., et al. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.06.014 · Cited by 108
Self-citationBochenek, G. (2004) · Thorax · doi:10.1136/thx.2003.013573 · Cited by 106
Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors
De Schryver, S., Halbrich, M., Clarke, A., La Vieille, S., Eisman, H., Alizadehfar, R., Joseph, L., Morris, J., & Ben-Shoshan, M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.09.001 · Cited by 96
Human basophils as effectors and immunomodulators of allergic inflammation and innate immunity
Gibbs, B. F. (2005) · Clinical and Experimental Medicine · doi:10.1007/s10238-005-0064-5 · Cited by 95
Valent, P., Akin, C., Nedoszytko, B., Bonadonna, P., Hartmann, K., Niedoszytko, M., Brockow, K., Siebenhaar, F., Triggiani, M., Arock, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239030 · Cited by 92
Self-citationKrauth, M. ‐., Mirkina, I., Herrmann, H., Baumgartner, C., Kneidinger, M., & Valent, P. (2009) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2009.03353.x · Cited by 89
Self-citationGülen, T., Akin, C., Bonadonna, P., Siebenhaar, F., Broesby-Olsen, S., Brockow, K., Niedoszytko, M., Nedoszytko, B., Oude Elberink, H. N. G., Butterfield, J. H., et al. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2021.06.011 · Cited by 83
Self-citationButterfield, J. H., & Weiler, C. R. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000144042 · Cited by 81
Wimazal, F., Geissler, P., Shnawa, P., Sperr, W. R., & Valent, P. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000329218 · Cited by 75
Self-citationBonadonna, P., Zanotti, R., Pagani, M., Bonifacio, M., Scaffidi, L., Olivieri, E., Franchini, M., Reccardini, F., Costantino, M. T., Roncallo, C., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.11.025 · Cited by 73
Self-citationSabato, V., Chovanec, J., Faber, M., Milner, J. D., Ebo, D., & Lyons, J. J. (2018) · Journal of Clinical Immunology · doi:10.1007/s10875-018-0506-y · Cited by 73
Bonadonna, P., Zanotti, R., Caruso, B., Castellani, L., Perbellini, O., Colarossi, S., Chilosi, M., Dama, A., Schiappoli, M., Pizzolo, G., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.014 · Cited by 72
Self-citationCarter, M. C., Metcalfe, D. D., Matito, A., Escribano, L., Butterfield, J. H., Schwartz, L. B., Bonadonna, P., Zanotti, R., Triggiani, M., Castells, M., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.063 · Cited by 72
Self-citationGenetic and ethnic risk factors associated with drug hypersensitivity
Kim, S., Ye, Y., Palikhe, N. S., Kim, J., & Park, H. (2010) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32833b1eb3 · Cited by 71
Omalizumab therapy for mast cell-mediator symptoms in patients with ISM, CM, MMAS, and MCAS
Lemal, R., Fouquet, G., Terriou, L., Vaes, M., Livideanu, C. B., Frenzel, L., Barete, S., Canioni, D., Lhermitte, L., Rossignol, J., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.03.039 · Cited by 70
Self-citationDua, S., Dowey, J., Foley, L., Islam, S., King, Y., Ewan, P., & Clark, A. T. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.01.006 · Cited by 67
Awad, J. A., Morrow, J. D., & Roberts, L. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90371-9 · Cited by 66
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis
Hartmann, K., Gotlib, J., Akin, C., Hermine, O., Awan, F. T., Hexner, E., Mauro, M. J., Menssen, H. D., Redhu, S., Knoll, S., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.044 · Cited by 59
Self-citationBöhm, A., Sonneck, K., Gleixner, K. V., Schuch, K., Pickl, W. F., Blatt, K., Peter, B., Herrmann, H., Schernthaner, G.-H., Pehamberger, H., et al. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.05.006 · Cited by 55
Self-citationMediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
Brockow, K., Plata‐Nazar, K., Lange, M., Nedoszytko, B., Niedoszytko, M., & Valent, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052684 · Cited by 53
Self-citationAssessing anaphylactic risk? Consider mast cell clonality
Metcalfe, D. D., & Schwartz, L. B. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.003 · Cited by 52
Sprinzl, B., Greiner, G., Uyanik, G., Arock, M., Haferlach, T., Sperr, W. R., Valent, P., & Hoermann, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052458 · Cited by 51
Self-citationAnaphylaxis and Mast Cell Disorders
Gülen, T., & Akin, C. (2022) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2021.09.007 · Cited by 51
Systemic mastocytosis as a risk factor for severe Hymenoptera sting–induced anaphylaxis
Álvarez‐Twöse, I., Bonadonna, P., Matito, A., Zanotti, R., González‐de‐Olano, D., Sánchez‐Muñoz, L., Morgado, J. M., Órfão, A., & Escribano, L. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.10.052 · Cited by 50
Self-citationValent, P., Horny, H.-P., Triggiani, M., & Arock, M. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323763 · Cited by 50
Self-citationValent, P. (2014) · Clinical & Experimental Allergy · doi:10.1111/cea.12318 · Cited by 47
Self-citationThe clinical relevance of basophil releasability
Marone, G., Spadaro, G., Patella, V., & Genovese, A. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90345-x · Cited by 46
da Silva, E. N., & Randall, K. L. (2013) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2013.07.004 · Cited by 45
Prolonged elevation of serum tryptase in idiopathic anaphylaxis
Shanmugam, G., Schwartz, L. B., & Khan, D. A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1356 · Cited by 43
Giannetti, M. P., Akin, C., Hufdhi, R., Hamilton, M. J., Weller, E., van Anrooij, B., Lyons, J. J., Hornick, J. L., Pinkus, G., Castells, M., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.11.017 · Cited by 43
Williams, H. C., & Grindlay, D. J. C. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03733.x · Cited by 42
Zhao, W., & Schwartz, L. (2004) · CRC Press eBooks · doi:10.1201/b13958-3 · Cited by 42
Idiopathic anaphylaxis yardstick
Carter, M. C., Akin, C., Castells, M., Scott, E. P., & Lieberman, P. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.08.024 · Cited by 41
Butterfield, J., & Weiler, C. R. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.02.021 · Cited by 41
Low frequency of IgE-mediated food hypersensitivity in mastocytosis
Jarkvist, J., Brockow, K., & Gülen, T. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.05.044 · Cited by 41
Self-citationProstaglandin D2 metabolite in urine is an index of food allergy
Maeda, S., Nakamura, T., Harada, H., Tachibana, Y., Aritake, K., Shimosawa, T., Yatomi, Y., & Murata, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-17798-w · Cited by 39
Grootens, J., Ungerstedt, J. S., Ekoff, M., Rönnberg, E., Klimkowska, M., Amini, R., Arock, M., Söderlund, S., Mattsson, M., Nilsson, G. P., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.089 · Cited by 34
Self-citationGülşen, A., Ruëff, F., & Jappe, U. (2021) · Allergologie select · doi:10.5414/alx02196e · Cited by 32
Atopic Dermatitis: A Review of Current Diagnostic Criteria and a Proposed Update to Management
Reynolds, M., Gorelick, J., & Bruno, M. (2020) · Journal of Drugs in Dermatology · doi:10.36849/jdd.2020.4737 · Cited by 31
Characterization of syk expression in human lung mast cells: relationship with function
Havard, S., Scola, A.-M., Kay, L. J., Ishmael, S. S., MacGlashan, D. W., & Peachell, P. T. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03667.x · Cited by 30
Cho, C., Nguyen, A., Bryant, K. J., O'Neill, S. G., & McNeil, H. P. (2016) · Immunity, Inflammation and Disease · doi:10.1002/iid3.94 · Cited by 30
Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2
Naranjo, A. N., Bandara, G., Bai, Y., Smelkinson, M. G., Tobío, A., Komarow, H. D., Boyden, S. E., Kastner, D. L., Metcalfe, D. D., & Olivera, A. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.936 · Cited by 30
Nakamura, T., Haider, S., Colicino, S., Murray, C. S., Holloway, J. W., Simpson, A., Cullinan, P., Čustović, A., & the STELAR investigators (2019) · British Journal of Dermatology · doi:10.1111/bjd.17853 · Cited by 29
Gene expression analysis predicts insect venom anaphylaxis in indolent systemic mastocytosis
Niedoszytko, M., Bruinenberg, M., van Doormaal, J. J., de Monchy, J. G. R., Nedoszytko, B., Koppelman, G. H., Nawijn, M. C., Wijmenga, C., Jassem, E., & Elberink, J. N. G. O. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02521.x · Cited by 28
Self-citationIdentification of a leukemia-initiating stem cell in human mast cell leukemia
Eisenwort, G., Sadovnik, I., Schwaab, J., Jawhar, M., Keller, A., Stefanzl, G., Berger, D., Blatt, K., Hoermann, G., Bilban, M., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0460-6 · Cited by 27
Self-citationInterleukin 13 gene polymorphism and susceptibility to asthma: a meta-regression and meta-analysis
Omraninava, M., Eslami, M. M., Aslani, S., Razi, B., Imani, D., & Feyzinia, S. (2020) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.180 · Cited by 26
Giannetti, M. P., Silver, J. N., Hufdhi, R., & Castells, M. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.10.022 · Cited by 22
Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis
Constantine, G. M., Bressler, P. B., Petroni, D., Metcalfe, D. D., & Carter, M. C. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.07.041 · Cited by 21
MacDonald, S. M., & Vonakis, B. M. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00082-2 · Cited by 19
Górska, A., Gruchała‐Niedoszytko, M., Niedoszytko, M., Maciejewska, A., Chełmińska, M., Skrzypski, M. T., Wasąg, B., Kaczkan, M., Lange, M., Nedoszytko, B., et al. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0397-7 · Cited by 19
Self-citationIdiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome
Giannetti, M. P., Akin, C., & Castells, M. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.10.048 · Cited by 19
Varney, V., Nicholas, A., Warner, A., & Sumar, N. (2019) · Journal of Asthma and Allergy · doi:10.2147/jaa.s213016 · Cited by 14
Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis
Smiljkovic, D., Kiss, R., Lupinek, C., Hoermann, G., Greiner, G., Witzeneder, N., Krajnik, G., Trautinger, F., Vrtala, S., Mittermann, I., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.04.030 · Cited by 13
Self-citationNiedoszytko, M., Ratajska, M., Chełmińska, M., Makowiecki, M., Malek, E., Siemińska, A., Limon, J., & Jassem, E. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000312634 · Cited by 12
Self-citationFernandes, I. C., Sampaio, R., Moreno, F., Garcia, J. P., Teixeira, M. D. A., Freitas, I. C., Neves, E., Jara‐Acevedo, M., Escribano, L., & Lima, M. (2017) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-017-0193-x · Cited by 10
Brock, I., Eng, N., & Maitland, A. L. (2021) · Journal of Medical Case Reports · doi:10.1186/s13256-021-03190-w · Cited by 10
Increased Releasability of Skin Mast Cells after Exercise in Patients with Exercise-induced Asthma
Choi, I. S., Koh, Y., Chung, S.-W., & Lim, H. (2004) · Journal of Korean Medical Science · doi:10.3346/jkms.2004.19.5.724 · Cited by 7
The Role of KIT Mutations in Anaphylaxis
Coulson, E., Zhou, S., & Akin, C. (2019) · Current Allergy and Asthma Reports · doi:10.1007/s11882-019-0863-5 · Cited by 5
Cited by
Allergy, Anaphylaxis, and Nonallergic Hypersensitivity: IgE, Mast Cells, and Beyond
Vitte, J., Vibhushan, S., Bratti, M., Montero-Hernández, J. E., & Blank, U. (2022) · Medical Principles and Practice · doi:10.1159/000527481 · Cited by 126
Allergy: Mechanistic insights into new methods of prevention and therapy
Akdiş, C. A., Akdiş, M., Boyd, S. D., Sampath, V., Galli, S. J., & Nadeau, K. C. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.add2563 · Cited by 87
The international consensus classification of mastocytosis and related entities
Leguit, R. J., Wang, S. A., George, T. I., Tzankov, A., & Orazi, A. (2023) · Virchows Archiv · doi:10.1007/s00428-022-03423-3 · Cited by 65
“Five different variants of MCAS are presently being recognized [3, 4]:”
BackgroundInfluentialTheoharides, T. C., Twahir, A., & Kempuraj, D. (2023) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2023.10.032 · Cited by 60
Mast cell activation syndrome: Current understanding and research needs
Castells, M., Giannetti, M. P., Hamilton, M. J., Novak, P., Pozdnyakova, O., Nicoloro-SantaBarbara, J., Jennings, S. V., Francomano, C., Kim, B., Glover, S. C., et al. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.05.025 · Cited by 45
Self-citation
Metadata
- Authors
- Valent, P., Hartmann, K., Bonadonna, P., Niedoszytko, M., Triggiani, M., Arock, M., & Brockow, K.
- Affiliations
- Ludwig Boltzmann Institute for Hematology and Oncology (AT)
- University of Basel (CH)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Gdańsk Medical University (PL)
- University of Salerno (IT)
- Pitié-Salpêtrière Hospital (FR)
- Helmholtz Munich (DE)
- Corresponding author
- Valent, Peter
- ORCID
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2022
- Volume
- 183
- Issue
- 7
- Pages
- 693-705
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- PMC
- PMC9393812
- OpenAlex
- W4281392104
- Cited by
- 55
- References
- 104
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 14 · 2023: 19 · 2022: 3
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by-nc)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- mast cell activation syndrome, anaphylaxis, serum tryptase, hereditary alpha-tryptasemia, mastocytosis, KIT mutations, atopy, IgE-dependent allergy, comorbidities, diagnostic criteria, mast cell stabilizers, personalized treatment
- MeSH terms
- Mast Cell Activation Syndrome, Anaphylaxis, Humans, Immunoglobulin E, Mast Cells, Mastocytosis, Quality of Life, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.